Brief: “Extra-Strength” 40U Formulation of Jeuveau Demonstrates Effects Lasting 26 Weeks in Phase II Data

Evolus

06/11/2023 13:47

Nov 6 (Reuters) - Evolus Inc  EOLS.O :
    * “EXTRA-STRENGTH” 40U FORMULATION OF JEUVEAU® DEMONSTRATES
EFFECTS LASTING 26 WEEKS IN PHASE II DATA PRESENTED AT 2023 ASDS
ANNUAL MEETING

Source text for Eikon:  ID:nBw9y79vYa 
Further company coverage:  EOLS.O 

 ((Reuters.Briefs@thomsonreuters.com;))